Add Company
Join Now

VentiRx Pharmaceuticals Revenue and Competitors

License our Company Data API

Summit, NJ USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • VentiRx Pharmaceuticals's estimated annual revenue is currently $1.7M per year.(i)
  • VentiRx Pharmaceuticals's estimated revenue per employee is $155,000

Employee Data

  • VentiRx Pharmaceuticals has 11 Employees.(i)
  • VentiRx Pharmaceuticals grew their employee count by -15% last year.

VentiRx Pharmaceuticals's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$8.5M55-21%N/AN/A
#2
$0.2M10%N/AN/A
#3
$8.5M55-29%N/AN/A
#4
$108.5M5002%N/AN/A
#5
$0.8M50%N/AN/A
#6
$0.6M40%N/AN/A
#7
$14.7M68-23%$206.4MN/A
#8
$492.2M1503-15%$568MN/A
#9
$1.1M7-42%N/AN/A
#10
$4.5M290%N/AN/A
Add Company

What Is VentiRx Pharmaceuticals?

VentiRx is a clinical stage biopharmaceutical company committed to the development and commercialization of novel Toll-like Receptor 8 (TLR8) immunotherapies for the treatment of cancer, respiratory and inflammatory diseases. VentiRx has a broad clinical pipeline. The lead clinical oncology asset, VTX-2337, is a small molecule TLR8 agonist, currently in multiple clinical trials in combination with chemotherapies and monoclonal antibodies. The company has entered into a worldwide strategic collaboration with Celgene Corporation for this program.

keywords:N/A

N/A

Total Funding

11

Number of Employees

$1.7M

Revenue (est)

-15%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A130%N/A
#2
$2M1614%N/A
#3
$1.4M16-11%N/A
#4
$2.5M180%N/A
#5
$3.5M18-10%N/A